CYTOF · Altamira Therapeutics Ltd.
Market Cap
$405,798
Shares
5.72M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2025-08-29 | 2025-06-30 | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-05-09 | — | |
| 6-K | 2025-04-30 | — | |
| 20-F | 2025-04-30 | 2024-12-31 | |
| 6-K | 2025-03-10 | — | |
| 6-K | 2024-12-20 | — | |
| 6-K | 2024-10-04 | — | |
| 6-K | 2024-09-24 | 2024-06-30 | |
| 6-K | 2024-09-19 | — | |
| 20-F/A | 2024-07-01 | 2023-12-31 | |
| 6-K | 2024-05-16 | — | |
| 20-F/A | 2024-04-22 | 2023-12-31 | |
| 6-K | 2024-04-16 | — | |
| 20-F | 2024-04-10 | 2023-12-31 | |
| 6-K | 2024-04-10 | — | |
| 6-K | 2024-01-19 | — | |
| 6-K | 2024-01-19 | — | |
| 6-K | 2023-12-11 | — | |
| 6-K | 2023-12-11 | — | |
| 6-K | 2023-12-08 | — | |
| 6-K | 2023-11-22 | — | |
| 6-K | 2023-11-21 | — | |
| 6-K | 2023-10-31 | — | |
| 6-K | 2023-10-04 | — | |
| 6-K | 2023-09-12 | 2023-06-30 | |
| 6-K/A | 2023-08-21 | 2022-06-30 | |
| 6-K | 2023-07-28 | — | |
| 6-K | 2023-07-26 | — | |
| 6-K | 2023-07-11 | — | |
| 6-K | 2023-07-05 | 2023-07-03 | |
| 6-K | 2023-06-30 | — | |
| 6-K | 2023-06-27 | — | |
| 6-K | 2023-06-15 | — | |
| 6-K | 2023-05-30 | — | |
| 6-K | 2023-05-26 | — | |
| 20-F | 2023-05-16 | 2022-12-31 | |
| 6-K | 2023-05-16 | — | |
| 6-K | 2023-05-02 | — | |
| 6-K | 2023-04-18 | — | |
| 6-K | 2023-04-13 | — | |
| 6-K | 2023-04-03 | — | |
| 6-K | 2023-03-09 | — | |
| 6-K | 2023-02-17 | — | |
| 6-K | 2023-01-27 | — | |
| 6-K | 2023-01-24 | — | |
| 6-K | 2022-12-19 | — | |
| 6-K | 2022-12-05 | — | |
| 6-K | 2022-11-30 | 2022-06-30 | |
| 6-K | 2022-11-09 | — |
Showing 1–50 of 94 filings